• Applications of germline genetic testing, tumor genomics, and other biomarkers are now routinely used in risk assessment, determination of treatment course, prognosis, and monitoring. • Imaging ...

In a recent comprehensive review published in Cyborg Bionic Systems, researchers led by Keyi Li from the General Hospital of Northern Theater Command in Shenyang, along with international ...

LELAND, NC (WWAY) — Most people know about the importance of protecting against skin cancer, but few talk about the second-most diagnosed cancer in men: prostate cancer. Anshu Guleria, M.D., is a ...

Petros Grivas, MD, PhD, expresses great enthusiasm for the 2025 ASCO Annual Meeting, highlighting its wealth of clinical trial data, educational sessions, and real-world insights. He is particularly ...

or on the link below. With the identification of genes and molecular imaging markers that confer prognostic or therapy-related information in prostate cancer, the importance of appropriate and ...